Tactile Systems Technology, Inc. Stock price

Equities

TCMD

US87357P1003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
16.25 USD +2.46% Intraday chart for Tactile Systems Technology, Inc. -1.63% +13.64%
Sales 2024 * 303M Sales 2025 * 343M Capitalization 386M
Net income 2024 * 13M Net income 2025 * 22M EV / Sales 2024 * 1.27 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.12 x
P/E ratio 2024 *
28.6 x
P/E ratio 2025 *
17.5 x
Employees 992
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.02%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Tactile Systems Technology, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Tactile Systems Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tactile Systems Technology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q4 Revenue $77.7M MT
Tactile Systems Technology, Inc. Provides Revenue Guidance for the Full Year 2024 CI
Piper Sandler Cuts Tactile Systems Technology Price Target to $23 From $30, Maintains Overweight Rating MT
Tactile Systems Technology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Tactile Systems Technology, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q3 Revenue $69.6M, vs. Street Est of $69.1M MT
Tactile Systems Technology, Inc. Updates Earnings Guidance for the Full Year 2023 CI
Tactile Systems Technology, Inc. Appoints Vindell Washington as Board of Directors CI
Oppenheimer Adjusts Tactile Systems Technology Price Target to $30 From $24, Maintains Outperform Rating MT
Tactile Systems Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Tactile Systems Technology, Inc., Q2 2023 Earnings Call, Aug 07, 2023
Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Posts Q2 Revenue $68.3M, vs. Street Est of $65.3M MT
More news

Latest transcript on Tactile Systems Technology, Inc.

1 day+2.46%
1 week-1.63%
Current month+6.56%
1 month+3.90%
3 months+11.45%
6 months+17.16%
Current year+13.64%
More quotes
1 week
15.23
Extreme 15.23
16.95
1 month
14.93
Extreme 14.93
16.95
Current year
11.96
Extreme 11.9583
16.95
1 year
9.70
Extreme 9.695
26.11
3 years
6.28
Extreme 6.28
61.13
5 years
6.28
Extreme 6.28
71.65
10 years
6.28
Extreme 6.28
76.63
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 20-06-07
Director of Finance/CFO 49 23-03-19
Chief Operating Officer - 21-10-31
Members of the board TitleAgeSince
Chairman 65 15-08-31
Director/Board Member 65 17-09-19
Director/Board Member - 23-10-01
More insiders
Date Price Change Volume
24-03-28 16.25 +2.46% 239,555
24-03-27 15.86 +2.59% 115,312
24-03-26 15.46 -3.37% 218,529
24-03-25 16 -2.68% 281,463
24-03-22 16.44 -0.48% 238,608

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
16.25 USD
Average target price
20.67 USD
Spread / Average Target
+27.18%
Consensus
  1. Stock
  2. Equities
  3. Stock Tactile Systems Technology, Inc. - Nasdaq